{"id":781005,"date":[{"year":1988,"month":10,"day":31}],"page":"2","source":"本报","region":"","masthead":"综合新闻","special_issue":"","column":"","genre":"","count":"268","ytitle":"","mtitle":"肿瘤又有新克星","ftitle":"上海生物所研制成人白细胞干扰素","authors":["薛备国"],"text":[{"type":"paragraph","text":"本报讯　一种能抑制肿瘤细胞生长和抗病毒繁殖的有效生物制剂——人白细胞干扰素在卫生部上海生物制品研究所开发成功。日前，该所已获卫生部许可，成为国内首家经国家卫生部门批准生产人白细胞干扰素的单位。"},{"type":"paragraph","text":"人白细胞干扰素是用健康人白细胞经病毒诱导后制成的蛋白质制剂。它对白血病、肝癌、淋巴细胞瘤、成骨肉瘤等肿瘤病人有较好疗效。此外，还可广泛应用于治疗乙型肝炎、甲型肝炎、流行性出血热、带状疱疹和子宫颈炎等多种病毒性疾病；能减轻各种肿瘤病人在化学药物治疗、放射治疗过程中所发生的副作用。　(薛备国)"}]}